| Literature DB >> 29951095 |
Jefferson Soares de Oliveira1, Moara E Silva Conceição Pinto2, Lucas de Araújo de Bastos Santana1, Antonione Santos Bezerra Pinto3, David di Lenardo1, Daniel Fernando Pereira Vasconcelos2.
Abstract
[This corrects the article DOI: 10.1155/2016/3719879.].Entities:
Year: 2018 PMID: 29951095 PMCID: PMC5987334 DOI: 10.1155/2018/5656189
Source DB: PubMed Journal: Int J Dent ISSN: 1687-8728
List of medicinal plants, experimental methods, and their biological effects on induced periodontitis.
| Plant species | Plant material | Route of administration | Animal used (gender) | Type of induction/time of analysis | Antibacterial effect1 | Bone loss/method2 | Anti-inflammatory activity3 | Reference | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Mixture of extracts (9 : 1 weight) | Oral |
| Injecting | Not evaluated | Reduced ABC/ | Reduced the | Almeida et al. [2] | ||
|
| Tulsi extract | Topical |
| Silk ligature/9 days | Not evaluated | Not reduced ABC/Stereo | Presented anti-inflammatory activity in a separate model (paw edema) | Hosadurga et al. [4] | ||
|
| Baicalin | Oral |
| Nylon ligature/7 days | Not evaluated | Reduced ABC/histology | Not evaluated | Cai et al. [6] | ||
|
| Berberine | Oral |
| Silk ligature/8 days | Not evaluated | Reduced ABC/ | Not evaluated | Tu et al. [7] | ||
|
| LongoVital® | Oral |
| Injecting | Not evaluated | Reduced ABC/Radio | Not evaluated | Klausen et al. [8] | ||
|
| Mangiferin (Sigma-Aldrich Co.) | Oral |
| Cotton ligature/1, 4, 7 days | Not evaluated | Reduced ABC/histology | Inhibited COX-2 expression, the rolling, and adhesion of leukocytes in the periodontal tissue | Carvalho et al. [9] | ||
|
| Curcumin (Sigma-Aldrich Co.) | Gavage |
| Nylon ligature/30 days | Not evaluated | Reduced ABC/histology | Reduced the expression of TNF- | Zhou et al. [10] | ||
|
| Magnolol (Sigma-Aldrich Co.) | Oral |
| Silk ligature/9 days |
| Reduced ABC/ | Inhibited neutrophil migration, MPO activity, and COX-2 and iNOS expression in gingival tissues | Lu et al. [11] | ||
|
| Bu-Shen-Gu-Chi-Wan (JiuZhiTang Pharmaceutical) | Oral |
| Injecting | Not evaluated | Improved the mineral density of the bone/ | Reduced levels of IL-1 | Yang et al. [12] | ||
|
| Pycnogenol® (Tradepia Co.) | Oral | Balb/c (male) | Injecting | Antibacterial activity against | Reduced ABC/Stereo | Not evaluated | Sugimoto et al. [13] | ||
|
| Aqueous extract containing tannin and phenolic compounds | Oral |
| Injecting | Antiadhesive properties against | Not evaluated | Reduced | Polak et al. [15] | ||
|
| Curcumin | Topical |
| Silk ligature/28 days | Not evaluated | Did not reduce ABC/Stereo | Exhibited anti-inflammatory activity in a separate model (paw edema) | Hosadurga et al. [16] | ||
|
| Extract containing catechin | Topical |
| Injecting | Not evaluated | Did not reduce ABC/histology | Reduced inflammatory cell infiltration and levels of TNF- | Maruyama et al. [19] | ||
|
| Aqueous extract | Oral |
| Injecting |
| Reduced ABC/Stereo | Not evaluated | Toyama et al. [20] | ||
|
| Andiroba oil | Oral |
| Cotton ligature/50 days | Not evaluated | Did not reduce ABC/histology | Reduced the quantity of inflammatory cells in histology | Carmona et al. [21] | ||
|
|
| Oral |
| Nylon ligature/1 day | Not evaluated | Not evaluated | Reduced gingival TNF- | Holanda Pinto et al. [22] | ||
|
| Extract containing catechin | Oral |
| Nylon ligature/7, 14, 28 days | Not evaluated | Reduced ABC/histology | Reduced | Cho et al. [23] | ||
|
| Mixture of dichloromethane and methanol extract | Topical |
| Cotton ligature/11 days |
| Did not reduce ABC/Stereo | Not evaluated | Barrella et al. [24] | ||
|
| Mixture of leaf essential oil and hydroalcoholic solution from bark | Topical |
| Nylon ligature/11 days | Prevented the growth of oral microorganisms from gingival tissue | Reduced ABC/histology | Reduced MPO activity and inhibited TNF- | Botelho et al. [25] | ||
|
| Carvacrol | Topical |
| Nylon ligature/11 days | Prevented the growth of oral microorganisms from gingival tissue | Reduced ABC/AFM | Reduced MPO activity in gingival tissue | Botelho et al. [26] | ||
|
| Methanolic extract | Oral |
| Silk ligature/8 days | Not evaluated | Reduced ABC/Stereo | Reduced inflammatory cell infiltration, vascular permeability, expression of NF- | Paterniti et al. [27] | ||
|
| Essential oil | Topical |
| Cotton ligature/11 days | Reduced in vivo frequency of | Reduced ABC/histology | Increment in the in vivo levels of IL-10 | Pimentel et al. [28] | ||
|
| Extract containing catechin | Topical |
| Injecting | Not evaluated | Reduced ABC/histology | Reduced inflammatory cell infiltration | Yoshinaga et al. [29] | ||
|
| Cocoa extract containing flavonoids | Oral |
| Cotton ligature/28 days | Not evaluated | Reduced ABC/histology | Reduced/oxidized glutathione ratio and neutrophil infiltration | Tomofuji et al. [30] | ||
|
| Ethanol extract | Subcutaneous |
| Nylon ligature/30 days | Not evaluated | Reduced the furcation region/histology | Reduced neutrophil accumulation in the gingival tissue | Benatti et al. [31] | ||
|
| Anethole | Intraperitoneal |
| Injecting | Not evaluated | Not evaluated | Reduced serum levels of IL-1 | Moradi et al. [32] | ||
|
| Modified curcumin | Gavage |
| Injecting | Not evaluated | Reduced ABC/Stereo, and | Reduced serum level of IL-1 | Elburki et al. [33] | ||
|
| Product of fermentation | Oral |
| Silk ligature/8 days | Not evaluated | Reduced ABC/Stereo | Reduced NF- | Paola et al. [34] | ||
|
| Ginkgo biloba extract | Oral |
| Silk ligature/11 days | Not evaluated | Reduced ABC/histology | Not evaluated | Sezer et al. [35] | ||
|
| Curcumin | Gavage |
| Cotton ligature/15 days | Not evaluated | Did not reduce ABC/ | Reduced the inflammatory cell infiltrate to gingival tissue | Guimarães et al. [36] | ||
1 Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitan, Streptococcus mutans, Streptococcus sanguinis, Enterococcus faecalis, and Fusobacterium nucleatum. 2ABC: alveolar bone crest, µCT: microcomputed tomography, AFM: atomic force microscopy, Stereo: stereomicroscopy, Radio: radiography. 3TNF-α: tumor necrosis factor α, hGF: hepatocyte growth factor, MPO: myeloperoxidase activity, IL-1β: interleukin-1 beta, IL-10: interleukin-10, NF-κB: nuclear factor kappa-β, COX-2: cyclooxygenase-2, and iNOS: inducible nitric oxide synthase.